Market Overview:
Clinical nutrition is a discipline which helps prevent, diagnose, and manage nutritional changes in patients linked to acute and chronic diseases and conditions. Nutrition provides people with the required amount of minerals, vitamins, water, fats, carbohydrates, and proteins essential for proper functioning of the body. It is recommended that everyone should consumes these seven nutrients on a daily basis to maintain their overall health. Thus, nutrition and nutritional care has gained wide clinical and scientific interest during the past decades. Clinical nutritionists provide individual counseling and develop meal plans that can change lives and help those who are dealing with many chronic diseases, such as heart disease, cancer, diabetes, kidney disease, and digestive disorders. Thus, there is an increasing demand for clinical nutrition.
Get Sample Report with Latest Covid19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/4446
Competitive Landscape:
Major players operating in the Canada clinical nutrition market are Koninklijke DSM N.V., Koru Nutrition Inc., Perrigo Company PLC, Mead Johnson & Company, LLC, DANONE S.A.,B. Braun Melsungen AG, NESTLÉ S.A., Fresenius Kabi AG, Baxter International Inc., and Abbott Laboratories, among others.
Key Market Drivers:
Increasing prevalence of chronic diseases, such as cancer, heart disease, diabetes, etc., across the world is expected to boost the growth of the Canada clinical nutrition market during the forecast period. Chronic diseases such as cancer, heart disease, and diabetes are the leading causes of death and disability in Canada. According to the Government of Canada, heart disease is the second leading cause of death and a leading cause of hospitalization, after cancer.
Moreover, increasing wariness among people about the health benefits of clinical nutrition and the introduction of novel products in the market is expected to aid in the growth of the Canada clinical nutrition market. For instance, Canada’s sweeping clinical practice guidelines (CPGs) for treating obesity in adults may soon become the foundation for evidence-based patient care globally, thanks to a new international adaptation program launched by the Obesity Canada in August 2021.
COVID-19 Impact Analysis:
Due to the rapid rise in deaths resulted from COVID-19 infection, the identification of drugs against this virus is an important requirement. Moreover, many pharma companies and research institutions are conducting studies to highlight the use of nutrition in COVID-19 patients. For example, in May 2020, a research team from the University of Alberta Hospital highlighted the deficiencies of vitamin D in COVID-19 patients. This in turn is expected to augment the growth of the market. However, the pandemic has impacted the supply and production of nutritional products. The pandemic has also restricted access to healthcare, which in turn is increasing the risk of individuals developing malnutrition. Thus, there is an increasing demand for nutritional products in this region.
Key Takeaways:
-
The Canada clinical nutrition market is expected to exhibit a CAGR of XX % during the forecast period due to the increasing prevalence of metabolic disorders, such as ulcerative colitis. For instance, in October 2021, Kaleido Biosciences announced topline data from the non-IND/CTA clinical study evaluating KB295, a novel microbiome metabolic therapy (MMT), in mild-to-moderate ulcerative colitis (UC).
-
The region is expected to witness robust growth in the Canada clinical nutrition market due to increasing prevalence of chronic diseases coupled with the growing geriatric population. According to 2019 Canadian population data, around 17% of the population (or around 6.5 million Canadians) are older than 65, and the number is growing rapidly. Aging population is prone to various medical conditions, such as chronic diseases.
Purchase This Premium Report To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/4446
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837